Home > Qtrly Results > JAGSONPAL PHARMACEUTICALS

JAGSONPAL PHARMACEUTICALS
Quarterly Results Analysis [Sep2024]

JAGSONPAL PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for JAGSONPAL PHARMACEUTICALS
Please provide your vote to see the results

JAGSONPAL PHARMACEUTICALS Quarterly Results

Standalone Sep2024
UnAudited
Jun2024
UnAudited
Mar2024
UnAudited
Dec2023
UnAudited
Sep2023
UnAudited
Jun2023
UnAudited
Mar2023
UnAudited
Dec2022
UnAudited
Revenues ₹75 Cr ₹61 Cr ₹43 Cr ₹47 Cr ₹58 Cr ₹60 Cr ₹55 Cr ₹60 Cr
Expenses ₹58 Cr ₹51 Cr ₹41 Cr ₹44 Cr ₹49 Cr ₹52 Cr ₹50 Cr ₹52 Cr
Operating Income ₹16 Cr ₹10 Cr ₹3 Cr ₹3 Cr ₹8 Cr ₹9 Cr ₹5 Cr ₹9 Cr
Other Income ₹2 Cr ₹1 Cr ₹2 Cr ₹3 Cr ₹2 Cr ₹2 Cr ₹3 Cr ₹2 Cr
Interest ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr
Depreciation ₹2 Cr ₹1 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr
Profit Before Tax ₹15 Cr ₹7 Cr ₹5 Cr ₹5 Cr ₹10 Cr ₹10 Cr ₹7 Cr ₹10 Cr
Profit After Tax ₹11 Cr ₹5 Cr ₹4 Cr ₹4 Cr ₹7 Cr ₹7 Cr ₹6 Cr ₹8 Cr
EPS ₹4.33 ₹2.01 ₹1.34 ₹1.51 ₹2.85 ₹2.85 ₹2.14 ₹2.97
Industry Peers & Returns1W1M1Y
JAGSONPAL PHARMACEUTICALS -6.1% 11.2% 71.7%
SUN PHARMACEUTICAL INDUSTRIES -0.1% 1.7% 45.7%
CIPLA 1.7% 0.5% 23.7%
DR REDDYS LABORATORIES 5.7% 12.4% 18.5%
ZYDUS LIFESCIENCES -1.4% 3.1% 44.8%
DIVIS LABORATORIES -0.1% -2.2% 56.9%
MANKIND PHARMA 4.2% 9.8% 49.8%
TORRENT PHARMACEUTICALS 2.2% 10.6% 61.7%
LUPIN 4.1% 5.1% 71.7%

JAGSONPAL PHARMACEUTICALS Quarterly Revenues

Revenues
Q-o-Q

21.57 %

Y-o-Y

29.16 %

Quarters Revenues % Change
Sep2024 ₹75 Cr
21.57
Jun2024 ₹61 Cr
41.28
Mar2024 ₹43 Cr
-7.93
Dec2023 ₹47 Cr
-18.32
Sep2023 ₹58 Cr
-3.86
Jun2023 ₹60 Cr
8.48
Mar2023 ₹55 Cr
-7.80
Dec2022 ₹60 Cr -

JAGSONPAL PHARMACEUTICALS Quarterly Operating Profit

Operating Profit
Q-o-Q

59.06 %

Y-o-Y

94.68 %

Quarters Operating Profit % Change
Sep2024 ₹16 Cr
59.06
Jun2024 ₹10 Cr
283.59
Mar2024 ₹3 Cr
-21.41
Dec2023 ₹3 Cr
-59.40
Sep2023 ₹8 Cr
-3.15
Jun2023 ₹9 Cr
58.86
Mar2023 ₹5 Cr
-37.03
Dec2022 ₹9 Cr -
Operating Margins
Q-o-Q

30.85 %

Y-o-Y

50.66 %

Quarters Operating Margin% % Change
Sep2024 21.8%
30.85
Jun2024 16.66%
171.34
Mar2024 6.14%
-14.60
Dec2023 7.19%
-50.31
Sep2023 14.47%
0.77
Jun2023 14.36%
46.38
Mar2023 9.81%
-31.69
Dec2022 14.36% -

JAGSONPAL PHARMACEUTICALS Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

115.03 %

Y-o-Y

53.36 %

Quarters Profit After Tax % Change
Sep2024 ₹11 Cr
115.03
Jun2024 ₹5 Cr
50.15
Mar2024 ₹4 Cr
-10.45
Dec2023 ₹4 Cr
-46.96
Sep2023 ₹7 Cr
-0.09
Jun2023 ₹7 Cr
33.51
Mar2023 ₹6 Cr
-28.04
Dec2022 ₹8 Cr -
PAT Margins
Q-o-Q

76.93 %

Y-o-Y

18.73 %

Quarters PAT Margin(%) % Change
Sep2024 15.34 %
76.93
Jun2024 8.67 %
6.25
Mar2024 8.16 %
-2.74
Dec2023 8.39 %
-35.06
Sep2023 12.92 %
3.94
Jun2023 12.43 %
23.07
Mar2023 10.1 %
-21.95
Dec2022 12.94 % -

JAGSONPAL PHARMACEUTICALS Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

115.42 %

Y-o-Y

51.93 %

Quarters EPS % Change
Sep2024 ₹4.33
115.42
Jun2024 ₹2.01
50.00
Mar2024 ₹1.34
-11.26
Dec2023 ₹1.51
-47.02
Sep2023 ₹2.85
0.00
Jun2023 ₹2.85
33.18
Mar2023 ₹2.14
-27.95
Dec2022 ₹2.97 -

You may also like the below Video Courses